Nerve growth factor secretion inducing composition
Patent 5059627 Issued on October 22, 1991. Estimated Expiration Date: 
March 2, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 2, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesQuinone compounds and their use in suppressing the production of SRS-A in mammals Method for therapy of ischemic disease Certain benzoquinones, naphthoquinones, corresponding hydroquinones which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like Anti-dementia agent Physiologically active and nutritional composition Patent #: 4851431 InventorsAssigneeApplicationNo. 487249 filed on 03/02/1990US Classes:514/688, C=O bonded directly to benzene ring (e.g., acetophenone, etc.)514/678, Benzene ring containing514/685, C=O bonded directly to benzene ring514/718Plural oxygensExaminersPrimary: Friedman,Assistant: Criares, T. J. Attorney, Agent or FirmForeign Patent References
International ClassesA01N 035/00A01N 031/14 Foreign Application Priority Data1989-08-24 JPAbstractA compound of the formula: ##STR1## wherein R1 is a lower alkyl group; R2 is a hydrogen atom or an alkyl or alkenyl group which may be substituted; R3 and R4 each independently means a lower alkyl or lower alkoxy group or, taken together, mean a butadienylene group; and X1 and X2 each means a free hydroxy group or an esterified or etherified hydroxy group, has nerve growth factor secretion inducing activity, and a mammal suffering from degenerative nervous system disorders such as senile dementia, Alzheimer's disease, etc. is treated by administering said compound to said mammal.Other References
| |
